180 related articles for article (PubMed ID: 22970250)
1. Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival.
Bauer L; Langer R; Becker K; Hapfelmeier A; Ott K; Novotny A; Höfler H; Keller G
PLoS One; 2012; 7(9):e44566. PubMed ID: 22970250
[TBL] [Abstract][Full Text] [Related]
2. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
4. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.
Sun Y; Gao X; Liu J; Kong QY; Wang XW; Chen XY; Wang Q; Cheng YF; Qu XX; Li H
Arch Pathol Lab Med; 2011 Apr; 135(4):451-8. PubMed ID: 21466361
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of glycogen synthase kinase 3β in human colorectal adenocarcinomas correlates with accumulation of CTNNB1.
Wang HL; Hart J; Fan L; Mustafi R; Bissonnette M
Clin Colorectal Cancer; 2011 Mar; 10(1):30-6. PubMed ID: 21609933
[TBL] [Abstract][Full Text] [Related]
7. Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.
Pospisil H; Herrmann A; Butherus K; Pirson S; Reich JG; Kemmner W
BMC Genomics; 2006 Jun; 7():148. PubMed ID: 16772034
[TBL] [Abstract][Full Text] [Related]
8. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study.
Bauer L; Takacs A; Slotta-Huspenina J; Langer R; Becker K; Novotny A; Ott K; Walch A; Hapfelmeier A; Keller G
Front Oncol; 2015; 5():94. PubMed ID: 25954607
[TBL] [Abstract][Full Text] [Related]
10. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
11. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
[TBL] [Abstract][Full Text] [Related]
12. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway.
Zhou Y; Wang Y; Wen J; Zhao H; Dong X; Zhang Z; Wang S; Shen L
Oncotarget; 2016 Mar; 7(13):16529-41. PubMed ID: 26918728
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
16. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
17. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
[TBL] [Abstract][Full Text] [Related]
18. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.
Li G; Zhang Z; Chen Z; Liu B; Wu H
Life Sci; 2021 Jul; 277():119419. PubMed ID: 33785336
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis.
Vallböhmer D; Drebber U; Schneider PM; Baldus S; Bollschweiler E; Brabender J; Warnecke-Eberz U; Mönig S; Hölscher AH; Metzger R
J Surg Oncol; 2009 Jun; 99(7):409-13. PubMed ID: 19347901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
